Publication | Closed Access

Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients

Hematological MalignancyDifferent Postremission StrategiesAgingElderly PatientsGeriatricsLongevityAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyMalignant Blood DisorderGeriatric MedicineMedicineMyeloid Neoplasia